EP1068591A1 — Counting device and inhaler including a counting device
Assigned to AstraZeneca AB · Expires 2001-01-17 · 25y expired
What this patent protects
A counting device, comprising: an input (105, 107) for receiving an input signal having at least three distinct input states; memory means (810) for storing a count; and means (620) responsive to a predetermined sequence of input states of said input signal to vary said count, wh…
USPTO Abstract
A counting device, comprising: an input (105, 107) for receiving an input signal having at least three distinct input states; memory means (810) for storing a count; and means (620) responsive to a predetermined sequence of input states of said input signal to vary said count, wherein said predetermined sequence includes the at least three input states.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.